RecallHawk

SOLU-MEDROL (METHYLPREDNISOLONE SODIUM SUCCINATE)

PHARMACIA AND UPJOHN

Summary

FDA approved SOLU-MEDROL (METHYLPREDNISOLONE SODIUM SUCCINATE) by PHARMACIA AND UPJOHN. NDA (New Drug) approval (Labeling) on 2025-11-04. INJECTABLE, INJECTION.

Details

Source

Drug Approval

External ID

NDA011856-143

Action Date

2025-11-04

Status

Approved

Category

drug

Product Code

NDA (New Drug)

Product Description

SOLU-MEDROL (generic: METHYLPREDNISOLONE SODIUM SUCCINATE), INJECTABLE, INJECTION. Application: NDA011856

Context & Analysis

Frequently Asked Questions

How often does PHARMACIA AND UPJOHN have FDA actions?

This is the only FDA action we have on record for PHARMACIA AND UPJOHN in our database.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "NDA011856-143" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions